Impax Asset Management Group plc Acquires New Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Impax Asset Management Group plc acquired a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the fourth quarter, HoldingsChannel reports. The institutional investor acquired 8,445 shares of the company’s stock, valued at approximately $660,000.

A number of other large investors have also made changes to their positions in the stock. Skylands Capital LLC boosted its stake in shares of GE HealthCare Technologies by 19.7% during the fourth quarter. Skylands Capital LLC now owns 156,790 shares of the company’s stock valued at $12,258,000 after acquiring an additional 25,815 shares during the last quarter. IFP Advisors Inc boosted its stake in GE HealthCare Technologies by 15.1% in the 4th quarter. IFP Advisors Inc now owns 2,743 shares of the company’s stock worth $215,000 after buying an additional 360 shares during the last quarter. Waverton Investment Management Ltd acquired a new stake in GE HealthCare Technologies in the 4th quarter worth about $48,977,000. Union Bancaire Privee UBP SA acquired a new stake in GE HealthCare Technologies in the 4th quarter worth about $280,000. Finally, MONECO Advisors LLC acquired a new stake in GE HealthCare Technologies in the 4th quarter worth about $245,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the company. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price target for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. Wells Fargo & Company raised their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research note on Friday, February 14th. Finally, Citigroup raised their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research note on Thursday, February 13th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $97.67.

GE HealthCare Technologies Stock Performance

GE HealthCare Technologies stock opened at $90.81 on Wednesday. The stock’s 50-day moving average is $85.49 and its 200-day moving average is $86.01. The company has a market cap of $41.53 billion, a price-to-earnings ratio of 20.97, a price-to-earnings-growth ratio of 3.19 and a beta of 1.15. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. GE HealthCare Technologies Inc. has a 12 month low of $74.51 and a 12 month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. The company had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. Equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.